BRKR logo

BRKR
Bruker Corp

867
Mkt Cap
$5.56B
Volume
963,008.00
52W High
$56.22
52W Low
$28.53
PE Ratio
-243.85
BRKR Fundamentals
Price
$36.26
Prev Close
$36.53
Open
$36.34
50D MA
$37.31
Beta
1.14
Avg. Volume
2.11M
EPS (Annual)
-$0.1482
P/B
2.25
Rev/Employee
$310,013.53
$8,949.20
Loading...
Loading...
News
all
press releases
Universal Beteiligungs und Servicegesellschaft mbH Sells 135,470 Shares of Bruker Corporation $BRKR
Universal Beteiligungs und Servicegesellschaft mbH lessened its stake in Bruker Corporation (NASDAQ:BRKR - Free Report) by 23.6% during the fourth quarter, according to its most recent Form 13F...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2026 financial results before market opening on Wednesday, May 6, 2026. The Company will host a conference call and...
Business Wire·5d ago
News Placeholder
Peregrine Capital Management LLC Raises Holdings in Bruker Corporation $BRKR
Peregrine Capital Management LLC increased its holdings in Bruker Corporation (NASDAQ:BRKR - Free Report) by 27,660.8% in the 4th quarter, according to its most recent disclosure with the SEC. The...
MarketBeat·5d ago
News Placeholder
Bruker (NASDAQ:BRKR) Stock Price Down 8.7% - Time to Sell?
Bruker (NASDAQ:BRKR) Shares Down 8.7% - Time to Sell...
MarketBeat·5d ago
News Placeholder
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 American Association for Cancer Research (AACR) Annual Meeting. At AACR, Bruker...
Business Wire·12d ago
News Placeholder
Insider Selling: Bruker (NASDAQ:BRKR) VP Sells 2,000 Shares of Stock
Bruker Corporation (NASDAQ:BRKR - Get Free Report) VP Mark Munch sold 2,000 shares of Bruker stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $39.90, for a total transaction of $79,800.00. Following the completion of the sale, the vice president directly...
MarketBeat·12d ago
News Placeholder
Bruker Launches MyGenius PRO High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division (Bruker Corporation, Nasdaq: BRKR) announces the European launch of MyGenius PRO, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology. Designed for...
Business Wire·12d ago
News Placeholder
Bruker Expands Industry-Leading MALDI Biotyper and IR Biotyper Workflows for Microbial Identification and Outbreak Management
At ESCMID Global 2026, Bruker announces important portfolio enhancements across microbial identification, outbreak analysis, and reflex nextgeneration sequencing (NGS) typing. These latest...
Business Wire·12d ago
News Placeholder
Bruker Corporation (NASDAQ:BRKR) Receives Average Recommendation of "Hold" from Brokerages
Bruker Corporation (NASDAQ:BRKR - Get Free Report) has received an average recommendation of "Hold" from the fifteen research firms that are presently covering the stock, MarketBeat.com reports. Two...
MarketBeat·12d ago
News Placeholder
Mark Munch Sells 2,000 Shares of Bruker (NASDAQ:BRKR) Stock
Bruker Corporation (NASDAQ:BRKR - Get Free Report) VP Mark Munch sold 2,000 shares of Bruker stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of...
MarketBeat·12d ago
<
1
2
...
>

Latest BRKR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.